KRISTINA HIPP: Open Payments
NPI 1669020236 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 26 payments from 11 companies in 2025. Trend: 2023 $1,869 · 2024 $1,418 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $171 |
| ABBVIE INC. | 4 | $91 |
| Merck Sharp & Dohme LLC | 3 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Gilead Sciences, Inc. | 2 | $60 |
| PFIZER INC. | 2 | $38 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: JARDIANCE, ZERBAXA, XIFAXAN, TEFLARO, ELIQUIS, LifeVest, AVYCAZ, LEQVIO.
Industry payments across NC — which companies pay providers there.
